U015 Clinically Relevant Updates in Dermatopathology: Where are the Gaps?
DESCRIPTION
Open admission to eligible categories, no tuition or ticket
Keeping up to date in dermatology subspecialties is challenging, yet it is beneficial to be aware of advances in dermatopathology, such as in immunohistochemistry and molecular techniques to assist in rendering a correct diagnosis. Additionally, new entities or variants of established entities are often introduced in dermatopathology journals, so shared knowledge of such could result in more accurate clinical-pathologic diagnoses. In this session, potential gaps in knowledge between clinical practice and dermatopathology advances are presented. These include a variety of topics such as melanocytic and lymphocytic neoplasms, drug-induced conditions, and systemic disease. Dermatologists and Dermatopathologists can benefit from this session.
LEARNING OBJECTIVES
Identify potential gaps in knowledge of clinically relevant developments in dermatopathology
Identify potential ways in which immunohistochemistry and molecular analysis can assist in diagnosis and management of melanocytic neoplasms.
Identify potential drugs that may induce inflammatory skin disorders
SCHEDULE
8:30 PM
Introductions
Jacqueline M. Junkins-Hopkins, MD, FAAD
8:32 PM
Melanocytic neoplasms: Updates and potential gaps
Allen Gordon Strickler, MD, PhD, MPH, FAAD
8:47 PM
Questions and Answers
Allen Gordon Strickler, MD, PhD, MPH, FAAD
8:52 PM
Selected drug-induced eruptions and non melanoma skin cancer: Updates and potential gaps
Emily Y. Chu, MD, PhD, FAAD
9:07 PM
Questions and Answers
Emily Y. Chu, MD, PhD, FAAD
9:12 PM
Cutaneous lymphoma and selective dermatopathology updates and potential gaps
Jacqueline M. Junkins-Hopkins, MD, FAAD
9:27 PM
Questions and Answers
Jacqueline M. Junkins-Hopkins, MD, FAAD
SPEAKERS
Emily Y. Chu, MD, PhD, FAAD
Jacqueline M. Junkins-Hopkins, MD, FAAD
Allen Gordon Strickler, MD, PhD, MPH, FAAD
SPEAKER DISCLOSURES
Emily Y. Chu, MD, PhD, FAAD
No financial relationships exist with ineligible companies.
Jacqueline M. Junkins-Hopkins, MD, FAAD
No financial relationships exist with ineligible companies.
Allen Gordon Strickler, MD, PhD, MPH, FAAD
No financial relationships exist with ineligible companies.